Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Protein-Tyrosine Kinase. Found 9 abstracts

Tarn C, Godwin AK. Molecular research directions in the management of gastrointestinal stromal tumors. Current treatment options in oncology. 2005 Nov;6(6):473-86.
Damjanov N, Meropol NJ. Epidermal growth factor receptor inhibitors for the treatment of colorectal cancer: a promise fulfilled?. Oncology (Williston Park). 2004 Apr;18(4):479-88; discussion 488, 493.
Katz BZ, Romer L, Miyamoto S, Volberg T, Matsumoto K, Cukierman E, Geiger B, Yamada KM. Targeting membrane-localized focal adhesion kinase to focal adhesions: roles of tyrosine phosphorylation and SRC family kinases. The Journal of biological chemistry. 2003 Aug;278(31):29115-20.
Carroll PR, Kantoff PW, Balk SP, Brown MA, D'Amico A V, George DJ, Grossfeld GD, Johnson CS, Kelly WK, Klotz L, Lee WR, Lubeck DP, McLeod DG, Oh WK, Pollack A, Sartor O, Smith MR, Hart C. Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer. Urology. 2002 Sep;60(3 Suppl 1):1-6.
Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CD, Joensuu H. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. The New England journal of medicine. 2002 Aug 15;347(7):472-80.
Allman D, Lindsley RC, DeMuth W, Rudd K, Shinton SA, Hardy RR. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol. 2001 Dec 15;167(12):6834-40.
Golemis EA, Ochs MF, Pugacheva EN. Signal transduction driving technology driving signal transduction: factors in the design of targeted therapies. J Cell Biochem Suppl. 2001 Jan;Suppl 37:42-52.
van Seventer GA, Salmen HJ, Law SF, O'Neill GM, Mullen MM, Franz AM, Kanner SB, Golemis EA, van Seventer JM. Focal adhesion kinase regulates beta1 integrin-dependent T cell migration through an HEF1 effector pathway. Eur J Immunol. 2001 May;31(5):1417-27.
Law SF, O'Neill GM, Fashena SJ, Einarson MB, Golemis EA. The docking protein HEF1 is an apoptotic mediator at focal adhesion sites. Mol Cell Biol. 2000 Jul;20(14):5184-95.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Protein-Tyrosine Kinase

Protein-Tyrosine Kinase Human Non-US Gov't Support metabolism genetics Mutation Signal Transduction US Gov't Support-PHS Antineoplastic Agents chemistry Phosphoproteins antagonists & inhibitors therapeutic use ai [Antagonists & Inhibitors] Mice Female src-Family Kinases Transfection Phosphorylation analogs & derivatives tu [Therapeutic Use] pathology drug therapy Pyrimidines Piperazines EC 2-7-1-112 (Protein-Tyrosine Kinase) Hela Cells enzymology physiology Male Animal drug effects 0 (Antineoplastic Agents) dt [Drug Therapy] Brachytherapy Protein Databases Tumor Necrosis Factor Oligopeptides Mitogen-Activated Protein Kinases Lymphocyte Activation 184475-35-2 (gefitinib) cytology Complement Receptors Cultured Cells Protein Isoforms Jurkat Cells Proto-Oncogene Proteins c-kit Gene Expression Combined Modality Therapy Mitosis Cellular Apoptosis Susceptibility Protein Immunoglobulin M Epidermal Growth Factor Receptor Mutagenesis Epidermal Growth Factor) EC 2-7-1-112 (Receptor Focal Adhesions Monoclonal Antibodies ge [Genetics] Cell Death adverse effects Multienzyme Complexes me [Metabolism] Pharmaceutical Technology Platelet-Derived Growth Factor) EC 2-7-1-112 (Receptors Chimeric Proteins Quinazolines Drug Design Gastrointestinal Stromal Tumors Colorectal Neoplasms Adolescent US Gov't Support-Non-PHS 0 (Piperazines) Cultured Tumor Cells Proto-Oncogene Protein c-kit Cysteine Endopeptidases Apoptosis T-Lymphocytes pd [Pharmacology] Protein Kinase Inhibitors Fibronectins 0 (cetuximab) immunology Knockout Mice Androgen Antagonists Monoclonal) 0 (Antibodies Platelet-Derived Growth Factor Receptors Phosphotyrosine Polymerase Chain Reaction Flow Cytometry Inhibitors] Spleen EC 2-7-1-112 (Proto-Oncogene Proteins c-kit) Clone Cells classification 0 (Quinazolines) Acetylcysteine 152459-95-5 (imatinib) Quality of Life Cell Lineage Adult Indirect Fluorescent Antibody Technique 0 (erlotinib) Cysteine Proteinase Inhibitors Survival Analysis 3T3 Cells Middle Age Stem Cells pharmacology CD29 Antigens Gastrointestinal Neoplasms Interleukin-2 Receptors Tyrosine 80 and over Aged Drug Delivery Systems Fibroblasts Remission Induction Recombinant Fusion Proteins IgE Receptors Peptide Fragments Poly(ADP-ribose) Polymerases Vinculin Immunophenotyping pharmacokinetics standards Forecasting 0 (Pyrimidines) Cell Membrane Lymphatic Metastasis Amino Acid Substitution Proteome Aged 0 (Protein Kinase Inhibitors) Caspases Neoplasm Staging NIH Research Support-Extramural Drug Resistance Inbred BALB C Mice Information Management Hormone Replacement Therapy Cell Movement Gonadorelin Leupeptins Enzyme Inhibitors Prostatectomy B-Lymphocyte Subsets Bromodeoxyuridine ai [Antagonists & Stromal Cells deficiency Cell Adhesion
Last updated on Wednesday, February 05, 2020